1. Home
  2. EVC vs VNDA Comparison

EVC vs VNDA Comparison

Compare EVC & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

HOLD

Current Price

$8.76

Market Cap

335.0M

Sector

Industrials

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$6.04

Market Cap

387.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVC
VNDA
Founded
1996
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
335.0M
387.9M
IPO Year
2000
2005

Fundamental Metrics

Financial Performance
Metric
EVC
VNDA
Price
$8.76
$6.04
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$14.90
AVG Volume (30 Days)
3.6M
1.0M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
5.35%
N/A
EPS Growth
47.59
N/A
EPS
0.13
N/A
Revenue
$536,034,000.00
$216,105,000.00
Revenue This Year
N/A
$21.35
Revenue Next Year
N/A
$37.40
P/E Ratio
$69.77
N/A
Revenue Growth
N/A
8.72
52 Week Low
$1.95
$4.14
52 Week High
$10.12
$9.91

Technical Indicators

Market Signals
Indicator
EVC
VNDA
Relative Strength Index (RSI) 58.58 39.38
Support Level $2.70 $5.85
Resistance Level $10.12 $6.73
Average True Range (ATR) 0.73 0.24
MACD -0.19 0.01
Stochastic Oscillator 47.55 8.61

Price Performance

Historical Comparison
EVC
VNDA

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the advertising and technology services segment. Geographically, the company generates the majority of its revenue from the United States.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: